Anzeige
Mehr »
Login
Sonntag, 26.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Der SILBER-STURM kommt - wie diese unterbewertete Firma die Investmentwelt aufmischt und Milliardenwerte hebt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema MEDIWOUND

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MiMediWound Ltd.: MediWound to Report First Quarter 2024 Financial Results2
22.03.Earnings call: MediWound forecasts growth with NexoBrid and EscharEx advances1
21.03.MediWound Ltd. - 20-F, Annual and transition report of foreign private issuers-
21.03.MediWound reports mixed Q4 results; initiates FY24 outlook1
21.03.MediWound Ltd.: MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update132$19 million revenue in 2023; $24 million projected revenue in 2024NexoBrid® commercially launched in U.S., Japan, IndiaPotential blockbuster EscharEx® to begin Phase III in the second half of 2024$42...
► Artikel lesen
21.03.MediWound Ltd. - 6-K, Report of foreign issuer1
20.03.Preview: MediWound's Earnings1
20.03.MediWound Q4 2023 Earnings Preview1
12.02.MediWound stock climbs 9% on Phase 2 data for wound care treatment2
12.02.MediWound Ltd. - 6-K, Report of foreign issuer2
05.02.MediWound Ltd.: MediWound to Participate in Two Upcoming Investor Conferences1
09.01.FDA accepts MediWound application for NexoBrid pediatric approval1
09.01.MediWound: FDA To Review NexoBrid SBLA For Removal Of Eschar In Pediatric Patients2
08.01.MediWound Ltd. - 6-K, Report of foreign issuer2
29.12.23MediWound Receives $6.7 Million U.S. DoD Funding For Advancing NexoBrid Development3
28.12.23Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development2
28.12.23MediWound Secures $6.7 Mln From US Department Of Defense For NexoBrid In Field-Care Burn Treatment-
28.12.23MediWound wins DoD funding to develop NexoBrid for U.S. Army1
28.12.23MediWound Ltd.: MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army2
28.12.23MediWound Ltd. - 6-K, Report of foreign issuer1
Seite:  Weiter >>